Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 79; no. 5; pp. e200 - e202
Main Authors Tosetti, Giulia, Degasperi, Elisabetta, Farina, Elisa, Primignani, Massimo, Lampertico, Pietro
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.11.2023
Online AccessGet full text

Cover

Loading…
Author Primignani, Massimo
Degasperi, Elisabetta
Lampertico, Pietro
Tosetti, Giulia
Farina, Elisa
Author_xml – sequence: 1
  givenname: Giulia
  surname: Tosetti
  fullname: Tosetti, Giulia
  organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
– sequence: 2
  givenname: Elisabetta
  surname: Degasperi
  fullname: Degasperi, Elisabetta
  organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
– sequence: 3
  givenname: Elisa
  surname: Farina
  fullname: Farina, Elisa
  organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
– sequence: 4
  givenname: Massimo
  orcidid: 0000-0003-1588-2643
  surname: Primignani
  fullname: Primignani, Massimo
  email: massimo.primignani@policlinico.mi.it
  organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
– sequence: 5
  givenname: Pietro
  surname: Lampertico
  fullname: Lampertico, Pietro
  organization: Division of Gastroenterology and Hepatology, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
BookMark eNp9kcGKFDEQhoOs4OzqC3jK0UuPlU6mk96L6KDuwoIX3WtIp6uZzGaSNkmvzKP4tmYc8aCwUJBQ9X9_kfyX5CLEgIS8ZrBmwLq3-_V-h_O6hZavoVbbPSMr1gE00Al2QVZVpBrVSvWCXOa8BwAOvViRn1uTHnF0PnpaIk04LhZp2SFNLj_QONERbTzMGLIpLgbqAp3rDUPJ9IcrO_p3iiO1LqVdzC5f09tMXal-xvsjDYhjHf_PLnUhvdne05hoXuY5Yc6nzof7dy_J88n4jK_-nFfk26ePX7c3zd2Xz7fb93eNFa0qjTASkG02kxgGsFMnEXAQEvhGyKEduALJkY-9MtABF4YxJTo-CmMMQ8kMvyJvzr5zit8XzEUfXLbovQkYl6xb2fNeyb6TVarOUptizgknbV35_S0lGec1A31KQ-_1KQ19SkNDrbaraPsPOid3MOn4NHR9hrC-_9Fh0ta74KzxD3jUY3RPwb8AToKnEg
CitedBy_id crossref_primary_10_14309_ajg_0000000000002569
crossref_primary_10_1016_j_cgh_2024_08_012
Cites_doi 10.1002/hep.23045
10.1016/j.jhep.2022.05.021
10.1016/j.jhep.2013.11.019
10.1136/gutjnl-2016-311735
10.14309/ajg.0000000000001158
10.1016/S0140-6736(18)31875-0
10.1053/j.gastro.2016.09.009
ContentType Journal Article
Copyright 2023 European Association for the Study of the Liver
Copyright_xml – notice: 2023 European Association for the Study of the Liver
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.jhep.2023.03.026
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0641
EndPage e202
ExternalDocumentID 10_1016_j_jhep_2023_03_026
S0168827823002039
Genre Correspondence
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
29K
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACIUM
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D-I
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LZ1
M27
M41
MJL
MO0
N9A
O-L
O9-
OAUVE
OC.
ON0
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
TEORI
UV1
WUQ
X7M
YOC
Z5R
ZGI
~G-
AAYXX
AFCTW
AGRNS
CITATION
RIG
7X8
ID FETCH-LOGICAL-c428t-4a70e155f4bb0cf67e0eb4703547b2b38073e3d98a06034a118463d4aaa1e71a3
ISSN 0168-8278
1600-0641
IngestDate Fri Jul 11 01:59:26 EDT 2025
Tue Jul 01 01:04:15 EDT 2025
Thu Apr 24 22:54:44 EDT 2025
Tue Aug 26 16:41:30 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c428t-4a70e155f4bb0cf67e0eb4703547b2b38073e3d98a06034a118463d4aaa1e71a3
Notes content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ORCID 0000-0003-1588-2643
OpenAccessLink http://www.journal-of-hepatology.eu/article/S0168827823002039/pdf
PQID 2793987967
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2793987967
crossref_citationtrail_10_1016_j_jhep_2023_03_026
crossref_primary_10_1016_j_jhep_2023_03_026
elsevier_clinicalkey_doi_10_1016_j_jhep_2023_03_026
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate November 2023
2023-11-00
20231101
PublicationDateYYYYMMDD 2023-11-01
PublicationDate_xml – month: 11
  year: 2023
  text: November 2023
PublicationDecade 2020
PublicationTitle Journal of hepatology
PublicationYear 2023
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Tripathi, Ferguson, Kochar, Leithead, Therapondos, McAvoy (bib2) 2009; 50
Shah, Azam, Rauf, Abid, Hamid, Jafri (bib3) 2014; 60
Villanueva, Albillos, Genescà, Garcia-Pagan, Calleja, Aracil (bib5) 2019; 393
Bhardwaj, Kedarisetty, Vashishtha, Bhadoria, Jindal, Kumar (bib4) 2017; 66
Tosetti, Degasperi, Farina, D’Ambrosio, Soffredini, Borghi (bib6) 2021; 116
Villanueva, Torres, Sarin, Shah, Tripathi, Brujats (bib1) 2022 Oct; 77
Nahon, Bourcier, Layese, Audureau, Cagnot, Marcellin (bib7) 2017; 152
Bhardwaj (10.1016/j.jhep.2023.03.026_bib4) 2017; 66
Nahon (10.1016/j.jhep.2023.03.026_bib7) 2017; 152
Villanueva (10.1016/j.jhep.2023.03.026_bib1) 2022; 77
Shah (10.1016/j.jhep.2023.03.026_bib3) 2014; 60
Tripathi (10.1016/j.jhep.2023.03.026_bib2) 2009; 50
Villanueva (10.1016/j.jhep.2023.03.026_bib5) 2019; 393
Tosetti (10.1016/j.jhep.2023.03.026_bib6) 2021; 116
References_xml – volume: 152
  start-page: 142
  year: 2017
  end-page: 156
  ident: bib7
  article-title: Eradication of Hepatitis C Virus infection in patients with cirrhosis reduces risk of liver and non-liver complications
  publication-title: Gastroenterology
– volume: 77
  start-page: 1014
  year: 2022 Oct
  end-page: 1025
  ident: bib1
  article-title: Carvedilol-IPD-MA-group and the Baveno Cooperation: an EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
  publication-title: J Hepatol
– volume: 50
  start-page: 825
  year: 2009
  end-page: 833
  ident: bib2
  article-title: Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
  publication-title: Hepatology
– volume: 60
  start-page: 757
  year: 2014
  end-page: 764
  ident: bib3
  article-title: Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial
  publication-title: J Hepatol
– volume: 116
  start-page: 1342
  year: 2021
  end-page: 1344
  ident: bib6
  article-title: Decompensation in Direct-Acting Antiviral cured Hepatitis C Virus compensated patients with clinically significant portal hypertension: too Rare to warrant universal B-Blocker Therapy
  publication-title: Am J Gastroenterol
– volume: 66
  start-page: 1838
  year: 2017
  end-page: 1894
  ident: bib4
  article-title: Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial
  publication-title: Gut
– volume: 393
  start-page: 1597
  year: 2019
  end-page: 1608
  ident: bib5
  article-title: β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
  publication-title: Lancet
– volume: 50
  start-page: 825
  issue: 3
  year: 2009
  ident: 10.1016/j.jhep.2023.03.026_bib2
  article-title: Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed
  publication-title: Hepatology
  doi: 10.1002/hep.23045
– volume: 77
  start-page: 1014
  issue: 4
  year: 2022
  ident: 10.1016/j.jhep.2023.03.026_bib1
  article-title: Carvedilol-IPD-MA-group and the Baveno Cooperation: an EASL Consortium. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2022.05.021
– volume: 60
  start-page: 757
  issue: 4
  year: 2014
  ident: 10.1016/j.jhep.2023.03.026_bib3
  article-title: Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2013.11.019
– volume: 66
  start-page: 1838
  issue: 10
  year: 2017
  ident: 10.1016/j.jhep.2023.03.026_bib4
  article-title: Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial
  publication-title: Gut
  doi: 10.1136/gutjnl-2016-311735
– volume: 116
  start-page: 1342
  issue: 6
  year: 2021
  ident: 10.1016/j.jhep.2023.03.026_bib6
  article-title: Decompensation in Direct-Acting Antiviral cured Hepatitis C Virus compensated patients with clinically significant portal hypertension: too Rare to warrant universal B-Blocker Therapy
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000001158
– volume: 393
  start-page: 1597
  issue: 10181
  year: 2019
  ident: 10.1016/j.jhep.2023.03.026_bib5
  article-title: β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)31875-0
– volume: 152
  start-page: 142
  year: 2017
  ident: 10.1016/j.jhep.2023.03.026_bib7
  article-title: Eradication of Hepatitis C Virus infection in patients with cirrhosis reduces risk of liver and non-liver complications
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2016.09.009
SSID ssj0003094
Score 2.441638
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage e200
Title Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV?
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0168827823002039
https://www.proquest.com/docview/2793987967
Volume 79
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIiEuiKcoLy0St8iRHxuvzQVBoLRI4UJa9WbtrjetI8uu_ECCA_-DP8NvY8a7dtIQKqgUWbGddVaezzsPfzNDyKuQyVQoTzqu1NphIsJHimtH8kBx7S2Z6rJc55_Dw2P26XR6Ohr92mAttY2cqO8780quI1U4BnLFLNn_kOxwUTgA30G-sAUJw_afZDwT1VdQPnmZowlZYRVWbTiDljCeaqSMg6cqek6jraNa95xzexbMTpVV1XlZZx1H7qgeZw1cUeT5t3EBGk6nO0a3SF4_nJ0gqb1uLzpOLR55d7LFF9wwe89B_zWXYvmLstaNYRV8zNo8GxTFe30msJB5ZvlnNYaJm-H0Abj5JqOtOzcs8tio7KwwvarGc3AOAI6bwQ0_sFl-Q8Ttj6wbEwQNIyfyTeuffhU3LWksWqcbS7I2pVB79Q67_k7VYaIYq8kK7sME59IVv_W36nR3mv8LzgAnAP4bvsmNb5CbPrgpuM5OfqwpRoEb29ryZr42acvwC7f_52-G0ZaJ0Nk9i7vkjpUcfWvQd4-MdHGf3JpbSsYD8nMNQtqU1ICQAggpgpCWS3oZhDQraA8jijCiGyCkAwhf06OaZg01EKQGgjvGIgQpQJCWFV1DkAIE3zwkxwcfFrNDx_b7cBQ4wQ2sFNzVYN8umZSuWoZcu1oyUElTxqUvsTVCoIM0joQbugET4BuzMEiZEMLT3BPBI7JXlIV-TGgYa9dTaYQRAeapQOpoybkOpOcKoXi8T7z-ZifKFsPHnix50rMeVwkKKEEBJS58_HCfjIcxF6YUzJW_DnoZJn2SM6jlBOB25aiXvbgTWOfx5Z0odNnWiQ-KNI54HPIn17ryU3J7_YA9I3tN1ernYE838kUH2t-UANGJ
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Carvedilol+to+reduce+the+risk+of+decompensation+in+patients+with+compensated+cirrhosis%3A+Is+it+really+needed+in+patients+with+cured+HCV+or+suppressed+HBV%3F&rft.jtitle=Journal+of+hepatology&rft.au=Tosetti%2C+Giulia&rft.au=Degasperi%2C+Elisabetta&rft.au=Farina%2C+Elisa&rft.au=Primignani%2C+Massimo&rft.date=2023-11-01&rft.pub=Elsevier+B.V&rft.issn=0168-8278&rft.volume=79&rft.issue=5&rft.spage=e200&rft.epage=e202&rft_id=info:doi/10.1016%2Fj.jhep.2023.03.026&rft.externalDocID=S0168827823002039
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-8278&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-8278&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-8278&client=summon